Evaluation of copy-number variants as modi ers of breast and ovarian cancer risk for pathogenic variant carriers

HIGHLIGHTS

• who: Corrected Correction et al. from the Department of Pathology, University of Otago, Christchurch, New ZealandMN, USA have published the research: Evaluation of copy-number variants as modi ers of breast and ovarian cancer risk for pathogenic variant carriers, in the Journal: (JOURNAL) of 20/04/2016
• what: CNV validation Accessible DNA samples from the study cohort were used to validate 29 putative deletion regions. The study focused on genomic deletions that overlapped gene regions, as this approach provided functionally important genomic regions for comparing CNV calls.
• how: The authors conducted a large . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.